%PDF-1.4
%
69 0 obj
<>
endobj
66 0 obj
<>
endobj
132 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-07-12T13:32:58Z
2024-03-28T12:21:20-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-28T12:21:20-07:00
application/pdf
Heather
2005-244-S75
uuid:9e76addf-1dd1-11b2-0a00-cf08275d6100
uuid:9e76ade3-1dd1-11b2-0a00-aa0000000000
endstream
endobj
55 0 obj
<>
endobj
56 0 obj
<>
endobj
70 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 33 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 35 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 37 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 39 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 41 0 R/Type/Page>>
endobj
21 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 43 0 R/Type/Page>>
endobj
24 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 45 0 R/Type/Page>>
endobj
27 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 47 0 R/Type/Page>>
endobj
30 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 49 0 R/Type/Page>>
endobj
166 0 obj
[170 0 R]
endobj
167 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
0 0 0 1 K
/GS1 gs
53.964 72 m
558.036 72 l
S
0 0 0 0 k
/GS0 gs
103.25 78.083 407.5 -10.833 re
f*
0.5 w
/GS1 gs
103.25 78.083 407.5 -10.833 re
S
53.964 742.5 243.036 -473.854 re
f*
BT
0 0 0 1 k
/T1_0 1 Tf
0.02499 Tw 8 0 0 8 69.78 735.7637 Tm
[(r)12.9 (ela)29.1 (ted disor)13.9 (ders)64 (.)-275 (Am J Med Sci 1998;315:359-66.)]TJ
-1.852 -1.2 Td
[(146.)-81 (W)54.9 (urtman RJ)108.9 (.)-275 (Str)13 (ess and the adr)12.9 (enocortical contr)33.9 (ol of)-367.8 (epinephrine)]TJ
1.852 -1.2 Td
[(synthesis)64 (.)-275 (Meta)43 (bolism 2002;51:11-4.)]TJ
-0.00929 Tc 0.02431 Tw -1.852 -1.2 Td
[(147.)-90.3 (R)42.7 (andich A,)-264.3 (Ge)15.6 (bhart GF)132.8 (.)-264.3 (V)74.7 (a)22.7 (gal af)29.7 (fer)13.6 (ent modula)29.7 (tion of)-357.1 (nociception.)]TJ
-0.00999 Tc 0.02499 Tw 1.852 -1.2 Td
[(Br)7.1 (ain R)53.9 (es R)53.9 (e)13.9 (v 1992;17:77-99.)]TJ
0 Tc -1.852 -1.2 Td
[(148.)-81 (W)82 (a)29 (tkins LR,)-275 (W)23 (iertelak EP)116 (,)-275 (Goehler LE,)-275 (et al.)-275 (Neur)33.9 (ocir)12.9 (cuitry of)]TJ
1.852 -1.2 Td
[(illness-induced h)55.9 (yper)7.1 (algesia.)-275 (Br)7.1 (ain R)54 (es 1994;639:283-99.)]TJ
-1.852 -1.2 Td
[(149.)-81 (P)12.9 (a)21 (pka RE,)-275 (Srini)13.9 (v)20 (asan B)29 (,)-275 (Miller KE,)-275 (Ha)40 (y)20 (ashi S)50.1 (.)-275 (Localiza)29.1 (tion of)]TJ
1.852 -1.2 Td
[(estr)33.9 (o)21 (gen r)12.9 (eceptor pr)33.9 (otein and estr)33.9 (o)21 (gen r)12.9 (eceptor messenger RN)21 (A)]TJ
0 -1.2 TD
[(in peripher)7.1 (al autonomic and sensory neur)33.9 (ons)64 (.)-275 (Neur)33.9 (oscience)]TJ
0 Tw T*
(1997;79:1153-63.)Tj
0.0092 Tc 0.0258 Tw -1.852 -1.2 Td
[(150.)-71.8 (Bond EF)119.4 (,)-285.8 (Heitk)32.2 (emper MM,)-285.7 (P)18.3 (erigo R.)-285.8 (Gastric emptying and)]TJ
0.00999 Tc 0.02499 Tw 1.852 -1.2 Td
[(gastric-intestinal tr)7.2 (ansit in r)7.1 (a)29 (ts with v)20.1 (arying o)33 (v)20 (arian hor)-20.7 (mone)]TJ
T*
[(sta)29.1 (tus)64 (.)-285 (Nurs R)54 (es 1996;45:218-24.)]TJ
0 Tc -1.852 -1.2 Td
[(151.)-81 (Khasar SG)43 (,)-275 (Gr)12.9 (een PG)43 (,)-275 (Gear R)116 (W)145 (,)-275 (Isenber)27.1 (g W)145 (,)-275 (Le)13.9 (vine JD)56.9 (.)]TJ
1.852 -1.2 Td
[(Gonadal hor)-20.7 (mones do not account f)40 (or se)13.9 (xual dimorphism in)]TJ
T*
[(v)20 (a)22 (gal modula)29.1 (tion of)-367.8 (nociception in the r)7.1 (a)29 (t.)-275 (J P)12.9 (ain 2003;4:190-6.)]TJ
-1.852 -1.2 Td
[(152.)-81 (Khasar SG)43 (,)-275 (Miao FJ)86.9 (,)-275 (Gear R)116 (W)145 (,)-275 (Gr)13 (een PG)43 (,)-275 (Le)13.9 (vine JD)56.9 (.)-275 (V)74 (a)22 (gal)]TJ
1.852 -1.2 Td
[(modula)29.1 (tion of)-367.8 (br)7.1 (ad)29.1 (ykinin-induced mechanical h)55.9 (yper)7.1 (algesia in the)]TJ
T*
[(female r)7.1 (a)29 (t.)-275 (J P)12.9 (ain 2003;4:278-83.)]TJ
-1.852 -1.2 Td
[(153.)-81 (Zuk)53 (o)27.1 (wska-Gr)33.9 (ojec Z,)-275 (Shen GH,)-275 (Ca)21 (pr)7.1 (ar)33.9 (o P)95.9 (A,)-275 (V)74 (az CA.)]TJ
1.852 -1.2 Td
[(Car)13.9 (dio)33 (v)20 (ascular neur)33.9 (opeptide Y and adr)12.9 (ener)27.1 (gic r)12.9 (esponses in str)12.9 (ess)]TJ
T*
[(ar)12.9 (e se)13.9 (xuall)21 (y dif)29 (fer)12.9 (entia)29.1 (ted.)-275 (Ph)55.9 (ysiol Beha)75 (v 1991;49:771-7.)]TJ
0.10001 Tw -1.852 -1.2 Td
[(154.)-81 (D)-75 (e)-75 (T)-1 (u)-75 (r)-62 (c)-75 (k)-75 ( K)-75 (H)-75 (,)-425 (V)31.9 (o)]TJ
0.075 Tc 0.02499 Tw 10.2801 0 Td
[(gel WH.)-350 (F)60.1 (actors inf)-6.8 (luencing plasma)]TJ
0.045 Tc -8.4281 -1.2 Td
[(ca)29.1 (techolamine le)13.9 (v)13.9 (els in r)7.1 (a)29 (ts during immobiliza)29.1 (tion.)]TJ
T*
[(Phar)-20.7 (macol Biochem Beha)75 (v 1980;13:129-31.)]TJ
0 Tc 0.05 Tw -1.852 -1.2 Td
[(155.)-81 (L)-25 (i)-11.1 (v)-11.1 (e)-25 (z)-38.7 (e)-25 (y)-25 ( G)-25 (T)79 (,)]TJ
0.02499 Tc 0.02499 Tw 7.5967 0 Td
[(Miller JM,)-300 (V)106.9 (o)21 (gel WH.)-300 (Plasma nor)12.9 (epinephrine)]TJ
-5.7447 -1.2 Td
[(epinephrine and corticoster)33.9 (one str)12.9 (ess r)12.9 (esponses to r)12.9 (estr)7.1 (aint in)]TJ
T*
[(indi)13.9 (vidual male and female r)7 (a)29.1 (ts and their corr)12.9 (ela)29.1 (tions)64 (.)]TJ
T*
[(Neur)33.9 (osci Lett 1985;62:51-6.)]TJ
0.00031 Tc 0 Tw -1.852 -1.2 Td
[(156.)-80.7 (Ta)]TJ
0.075 Tc 0.02499 Tw 3.055 0 Td
[(ylor J)86.9 (,)-350 (W)96 (ey)7.1 (ers P)116 (,)-350 (Harris N)56.9 (,)-350 (V)106.9 (o)21 (gel WH.)-350 (The plasma)]TJ
0.035 Tc -1.203 -1.2 Td
[(ca)29.1 (techolamine str)13 (ess r)13 (esponse is char)7.1 (acteristic f)40.1 (or a gi)14 (v)13.9 (en)]TJ
T*
[(animal o)33 (v)13.9 (er a one-y)7.1 (ear period.)-310 (Ph)55.9 (ysiol Beha)75 (v 1989;46:853-6.)]TJ
0 Tc -1.852 -1.2 Td
[(157.)-81 (Ng A)146 (V)127.9 (,)-275 (Callister R,)-275 (J)52 (ohnson DG)43 (,)-275 (Seals DR.)-275 (Age and gender)]TJ
1.852 -1.2 Td
[(inf)-6.8 (luence m)21 (uscle sympa)29.1 (thetic nerv)13.9 (e acti)13.9 (vity a)29.1 (t r)12.9 (est in health)55.9 (y)]TJ
T*
[(humans)64 (.)-275 (Hypertension 1993;21:498-503.)]TJ
-1.852 -1.2 Td
[(158.)-81 (Kirschbaum C)29.1 (,)-275 (Schommer N)56.9 (,)-275 (F)39.1 (eder)12.9 (enk)53 (o I,)-275 (et al.)-275 (Short-ter)-20.7 (m)]TJ
0.045 Tc 1.852 -1.2 Td
[(estr)7.1 (adiol tr)13 (ea)29.1 (tment enhances pituitary-adr)13 (enal axis and)]TJ
T*
[(sympa)29.1 (thetic r)13 (esponses to psy)14 (chosocial str)13 (ess in health)55.9 (y)]TJ
T*
[(y)40 (oung men.)-320 (J Clin Endocrinol Meta)43 (b 1996;81:3639-43.)]TJ
-0.0094 Tc 0.0244 Tw -1.852 -1.2 Td
[(159.)-90.4 (Staud R.)-264.5 (Evidence of)-357.2 (in)40.6 (v)27.7 (olv)14.5 (ement of)-357.2 (centr)7.7 (al neur)7.7 (al mechanisms in)]TJ
-0.00999 Tc 0.02499 Tw 1.852 -1.2 Td
[(gener)7.1 (a)29.1 (ting fibr)33.9 (om)27.1 (y)20 (algia pain.)-265.1 (Curr Rheuma)29 (tol R)53.9 (ep 2002;4:299-305.)]TJ
0 Tc -1.852 -1.2 Td
[(160.)-81 (Br)7.1 (adley LA,)-275 (McK)33.9 (endr)12.9 (ee-Smith NL.)-275 (Centr)7.1 (al nerv)27.1 (ous system)]TJ
1.852 -1.2 Td
[(mechanisms of)-367.8 (pain in fibr)33.9 (om)27.1 (y)20 (algia and other m)21 (usculosk)33 (eletal)]TJ
T*
[(disor)13.9 (ders:)-275 (beha)75 (vior)7.1 (al and psy)13.9 (cholo)21 (gic tr)12.9 (ea)29.1 (tment a)21 (ppr)33.9 (oaches)64 (.)-275 (Curr)]TJ
T*
[(Opin Rheuma)29.1 (tol 2002;14:45-51.)]TJ
-1.852 -1.2 Td
[(161.)-81 (Staud R,)-275 (Smither)-20.7 (man ML.)-275 (P)19 (eripher)7.1 (al and centr)7.1 (al sensitiza)29 (tion in)]TJ
1.852 -1.2 Td
[(fibr)33.9 (om)27.1 (y)20 (algia:)-275 (pa)29.1 (tho)21 (genetic r)33.9 (ole)56.9 (.)-275 (Curr P)12.9 (ain Headache R)54 (ep)]TJ
0 Tw T*
(2002;6:259-66.)Tj
ET
0 0 0 0 k
315 742.5 243.036 -652.464 re
f*
BT
0 0 0 1 k
/T1_0 1 Tf
0.02499 Tw 8 0 0 8 316 735.7637 Tm
[(162.)-81 (Khasar SG)43 (,)-275 (Gr)12.9 (een PG)43 (,)-275 (Miao FJP)116 (,)-275 (Le)13.9 (vine JD)56.9 (.)-275 (V)74 (a)22 (gal modula)29.1 (tion)]TJ
1.852 -1.2 Td
[(of)-367.8 (nociception is media)29.1 (ted b)20 (y adr)12.9 (enomedullary epinephrine in the)]TJ
T*
[(r)7.1 (a)29 (t.)-275 (Eur J Neur)33.9 (osci 2003;17:909-15.)]TJ
0 Tw -1.852 -1.2 Td
(163.)Tj
0.015 Tc 0.02499 Tw 1.852 0 Td
[(Schw)19.1 (artz GJ)86.9 (,)-290 (Mor)7.1 (an TH.)-290 (Sub-dia)21 (phr)7.1 (a)22 (gma)29.1 (tic v)20 (a)22 (gal af)29.1 (fer)12.9 (ent)]TJ
T*
[(integr)7.1 (a)29.1 (tion of)-382.8 (meal-r)13 (ela)29.1 (ted gastr)33.9 (ointestinal signals)64 (.)-290 (Neur)34 (osci)]TJ
T*
[(Biobeha)75 (v R)54 (e)13.9 (v 1996:20:47-56.)]TJ
0 Tc 0 Tw -1.852 -1.2 Td
(164.)Tj
-0.02499 Tc 0.02499 Tw 1.852 0 Td
[(Schw)19.1 (artz GJ)86.9 (,)-250 (McHugh PR,)-250 (Mor)7.1 (an TH.)-250 (Phar)-20.7 (macolo)21 (gical dissocia)29.1 (tion)]TJ
T*
[(of)-342.8 (r)12.9 (esponses to CCK and gastric loads in r)7.2 (a)29.1 (t mechanosensiti)14 (v)13.9 (e v)20 (a)22 (gal)]TJ
T*
[(af)29.1 (fer)13 (ents)64 (.)-250 (Am J Ph)55.9 (ysiol 1994;267:R303-8.)]TJ
0 Tc -1.852 -1.2 Td
[(165.)-81 (Holz)-13.7 (er HH,)-275 (T)74 (ur)13.9 (k)33 (elson CM,)-275 (Solomon TE,)-275 (R)42 (a)40 (ybould HE.)]TJ
1.852 -1.2 Td
[(Intestinal lipid inhibits gastric emptying via CCK and a v)20 (a)22 (gal)]TJ
T*
[(ca)21 (psaicin-sensiti)13.9 (v)13.9 (e af)29.1 (fer)12.9 (ent pa)29.1 (thw)19.1 (a)40 (y in r)7.1 (a)29 (ts)64 (.)-275 (Am J Ph)55.9 (ysiol)]TJ
0 Tw T*
(1994;267:G625-9.)Tj
0.02499 Tw -1.852 -1.2 Td
[(166.)-81 (Bluthe RM,)-275 (Michaud B)29.1 (,)-275 (K)33.9 (elley KW)145 (,)-275 (Dantz)-13.7 (er R.)-275 (V)74 (a)22 (gotom)27.1 (y)]TJ
1.852 -1.2 Td
[(b)13.9 (locks beha)75 (viour)7.1 (al ef)29.1 (fects of)-367.8 (inter)7.1 (leukin-1 injected via the)]TJ
T*
[(intr)7.1 (a)21 (peritoneal r)33.9 (oute b)22 (ut not via other systemic r)33.9 (outes)64 (.)]TJ
T*
[(Neur)33.9 (or)12.9 (eport 1996;7:2823-7.)]TJ
-1.852 -1.2 Td
[(167.)-81 (La)40 (y)7.1 (e S)43 (,)-275 (Bluthe RM,)-275 (K)33.9 (ent S)43 (,)-275 (et al.)-275 (Subdia)21 (phr)7.1 (a)22 (gma)29.1 (tic v)20 (a)22 (gotom)27.1 (y)]TJ
1.852 -1.2 Td
[(b)13.9 (locks induction of)-367.8 (IL-1 beta mRN)21 (A in mice br)7.1 (ain in r)12.9 (esponse to)]TJ
T*
[(peripher)7.1 (al LPS)50.1 (.)-275 (Am J Ph)55.9 (ysiol 1995;268:R1327-31.)]TJ
-1.852 -1.2 Td
[(168.)-81 (W)82 (a)29.1 (tkins LR,)-275 (Maier SF)120.1 (,)-275 (Goehler LE.)-275 (Imm)21 (une acti)13.9 (v)20 (a)29.1 (tion:)-275 (the r)33.9 (ole)]TJ
1.852 -1.2 Td
[(of)-367.8 (pr)33.9 (o-inf)-6.8 (lamma)29.1 (tory cytokines in inf)-6.8 (lamma)29.1 (tion illness r)12.9 (esponses)]TJ
T*
[(and pa)29.1 (tholo)21 (gical pain sta)29.1 (tes)64 (.)-275 (P)12.9 (ain 1995;63:289-302.)]TJ
-1.852 -1.2 Td
[(169.)-81 (Hansen MK,)-275 (Krueger JM.)-275 (Subdia)21 (phr)7.1 (a)22 (gma)29.1 (tic v)20 (a)22 (gotom)27.1 (y b)13.9 (locks)]TJ
1.852 -1.2 Td
[(the sleep- and fe)13.9 (v)13.9 (er)16.1 (-pr)33.9 (omoting ef)29.1 (fects of)-367.8 (inter)7.1 (leukin-1 beta.)-275 (Am J)]TJ
T*
[(Ph)55.9 (ysiol 1997;273:R1246-53.)]TJ
0 Tw -1.852 -1.2 Td
(170.)Tj
0.03999 Tc 0.02499 Tw 1.852 0 Td
[(Opp MR,)-315 (T)101.1 (oth LA.)-315 (Somno)21 (genic and p)12.9 (yr)33.9 (o)21 (genic ef)29 (fects of)]TJ
T*
[(inter)7.1 (leukin-1 beta and lipopol)20.9 (ysaccharide in intact and)]TJ
T*
[(v)20 (a)22 (gotomiz)-13.7 (ed r)7.1 (a)29.1 (ts)64 (.)-315 (Life Sci 1998;62:923-36.)]TJ
0 Tc 0 Tw -1.852 -1.2 Td
[(171.)-81 (A)15 (r)]TJ
-0.015 Tc 0.02499 Tw 2.9441 0 Td
[(onof)29.1 (f)-352.8 (GM.)-260 (My)40 (ofascial pain syndr)33.9 (ome and fibr)33.9 (om)27.1 (y)20 (algia:)-260 (a critical)]TJ
-1.0921 -1.2 Td
[(assessment and alterna)29.1 (te vie)13.9 (w)102.1 (.)-260 (Clin J P)12.9 (ain 1998;14:74-85.)]TJ
0 Tc -1.852 -1.2 Td
[(172.)-81 (J)47.1 (acobsen S)43 (,)-275 (P)19.1 (etersen IS)43 (,)-275 (Danneskiold-Samsoe B)43 (.)-275 (Clinical fea)29.1 (tur)13 (es)]TJ
1.852 -1.2 Td
[(in pa)29.1 (tients with chr)33.9 (onic m)21 (uscle pain \320 with special r)12.9 (efer)13 (ence to)]TJ
T*
[(fibr)33.9 (om)27.1 (y)20 (algia.)-275 (Scand J Rheuma)29 (tol 1993;22:69-76.)]TJ
-1.852 -1.2 Td
[(173.)-81 (Miao FJ)86.9 (,)-275 (J)47.1 (anig W)145 (,)-275 (Gr)12.9 (een PG)43 (,)-275 (Le)13.9 (vine JD)56.9 (.)-275 (Inhibition of)]TJ
-0.005 Tc 1.852 -1.2 Td
[(br)7.1 (ad)29.1 (ykinin-induced plasma e)13.8 (xtr)7.1 (a)74.9 (v)20 (asa)29 (tion pr)33.9 (oduced b)20 (y no)27.1 (xious)]TJ
T*
[(cutaneous and viscer)7 (al stim)21 (uli and its modula)29 (tion b)20 (y v)20 (a)22 (gal acti)13.9 (vity)115 (.)]TJ
T*
[(J Neur)33.9 (oph)55.9 (ysiol 1997;78:1285-92.)]TJ
0 Tc -1.852 -1.2 Td
[(174.)-81 (Cohen H,)-275 (Neumann L,)-275 (Shor)12.9 (e M,)-275 (Amir M,)-275 (Cassuto Y)163.1 (,)-275 (Buskila D)56.9 (.)]TJ
1.852 -1.2 Td
[(A)56.9 (utonomic d)29.1 (ysfunction in pa)29.1 (tients with fibr)33.9 (om)27.1 (y)20 (algia:)-275 (a)21 (pplica)29.1 (tion)]TJ
T*
[(of)-367.8 (po)27.1 (w)14.9 (er spectr)7.1 (al anal)21 (ysis of)-367.8 (heart r)7.1 (a)29.1 (te v)20 (aria)43 (bility)115 (.)-275 (Semin Arthritis)]TJ
T*
(Rheum 2000;29:217-27.)Tj
0 Tw -1.852 -1.2 Td
[(175.)-81 (T)]TJ
-0.03999 Tc 0.02499 Tw 2.3779 0 Td
[(ougas G)65 (.)-235 (The autonomic nerv)27.1 (ous system in functional bo)27.3 (w)14.9 (el disor)13.9 (ders)64 (.)]TJ
-0.5259 -1.2 Td
[(Can J Gastr)34 (oenter)34 (ol 1999;13 Suppl A:15A-17A.)]TJ
ET
0 0 0 0 k
53.964 64.8 513.774 -14.986 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
0 Tc 8 0 0 8 54.964 55.055 Tm
[(Le)22 (vine and R)13.9 (eic)21 (hling:)-275 (Ner)21 (v)13.9 (e of)-345.8 (that disease)]TJ
0 Tw 61.9536 0 Td
(37)Tj
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_2 8 Tf
106.328 69 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
49 0 obj
<>stream
8;Z\7!H*QE%*SZ8R.!_#`-+bqEAuOGXZ>dgTVRV.\=3;P^D1ACgLn.NUH[KTqf\*/
k%0f)g@!!?s,JE$Z`i0uqgN\'jU/!)mC?63i/'-%$/2-A-ij`:T3.aLAogPpDATKd
gMB9=/+u_[B#rs,p*I!qQHS^m)S4q^7D.%eI
NIg6=UgUR7+E/hr2;poR.au%/+-U_?7\^997E:.Gpp*@P`+6(<,#hRf347!C)MV,W
e8n/s!\/IP9Zj\.[Gk4?RNdW\cdj@KC4`\%iMa$`71a8843kIR"SM
D4),NWEG9bDYL6;Jp"n9D$>Bh2DS!n?g5[$s0;eGRjf))4V83"!ZjRiq*A#*!?TbK
-G7G;)+PVT&s]EG5OYKPZMg-=09pl/AGMa1T0?N&6.K\7:N3i=,O8
fl?pa\GFJFq=.gs@`=3>/,ii,#OsVr+9'Z8qs>+KReRd$2&1(l~>
endstream
endobj
53 0 obj
[/Indexed/DeviceRGB 255 52 0 R]
endobj
52 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
77 0 obj
<>
endobj
98 0 obj
<>
endobj
113 0 obj
<>
endobj
137 0 obj
<>
endobj
99 0 obj
<>
endobj
104 0 obj
<>stream
Hl{TWg3DP2BΌ-]["bՊB!!@"ޠHA"VW]]ZZ]K?z?wٌpw]zQ1rͪ~_
UF
RL`puHpۍX;'te{JL7-5/]]
ԺmZ~j4cYwj_h1~yl*^yoqr<>Q>RJįUńQ>je/h^~XV>oGby2mzM91ܺqFb6[,`pl0f}aJ̈S4Qɣ$*_|[ֶD7ǰc.j7Ϯs\и'}IrNPz
75'Sx;)KWKx e&9UTG,MWi5*CAzQoGnf,%KDJ4poQ+@[vmJժUZV(?ѢNQɖPE&I 2g jv@~H_pDϋDړ n=xfU> TfL[R$[>IjsA2[r )NS4^ΘuTyeDSGIAUN5M`s_$HNǫRW0ȋ<Z1[WVj^8!:&;O|\>>yn{deed\39)1Ge}@
%5Uʹr
6^Ja&d=]ˎqTwSe=-KgK2ҢL[bM[vsD*K
ݲFZ} O%,J%Qft:3zq",(tC[3d|xhtEDIRrn
P\2D<̻iZ@QSW݀"!:BP׆@R7ۏFӓXK\ݻUR$FEf-;qCpDA?Õ\dW7#Q㉂e#*iq7Aj~$45swdO<~4c͔M-AyOl:4wrMy1K
!CXj0rW{ޑQ6;{1
g7l-_l}[OGٍ6뽆KKÃ36
7~kb
`1df
Fh"D7?gǗ*Yq"n].t6֠`B|z oB==ڟhv@ŀwGVYKRY-NЪU#>2ҶgTeT[xax佁&o,jv^Q
ui%Bf ]Ei
B
3u:mVR5(ol*-o8i6:g)D53i=v_;7 >EJdh%=c[ګ[*.U$FҢ :vG`uKSM#?MeYItF+A/#hcRҴ]zS6Cː#77JJٞ_BtdGxgdevYݚ|A!#
AplL@ \2&(oԕIl;U~%^+zX+/$ibͶVVr=9آ8S(cE5[yicZv!CgPg]5LQõPDžڼyZaCJXQʜ&=-zS]7qR 7"1/WZ_jW\"ZIdN^df'p%$G( 7
~. p7d{f@rx8&VL7aw4+*>*bDy²avYX`x)o$& GEmQ66wֻw>~b:ze0a1jE3IDB۠c
770̖7=>h#6xA6AcH3F^/bѲFO^B
oHm
[5 0vE$lH0CsK8bb^0A
vGU](NDex}̳2&ڌEF&CY;y*ICL\f(;O[ƕp.&Gn6.ۜcS5
`rLj\ǀ>͒6RUx`6o{ tʿUDA~VY%PDb+
g)^+f%*f;?f7("L}Z@բ$#1/!
~An oJ@4v|,1x7bNM3Ey *mR2El+ nl ATjųѪrB=h9X
P]5WTKUJ[R+&Dr%FGZ%tYQRnU0:(HƂc<9
y|x˅hϖ0QVsx4/=m62Ylw:)UWi$eM6t ӫ>#&w7r>^ $"GEU̮|ڒO1^{^psnG55*{mV*skl"M(ŝc`:
&K%6ٓelGHp@IsΔT̰ y.~W,CL?gXD#2UB<u
m}NuYѰ&At010ԉtK^w/X